NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE218782 Query DataSets for GSE218782
Status Public on Nov 17, 2023
Title Increased HRD score in cisplatin resistant penile cancer cells
Organism Homo sapiens
Experiment type Genome variation profiling by SNP array
Summary HRD Score was generated from a penile carcinoma cell line resistant to 5FU and CDDP as well as cross resistant cell line.
 
Overall design Array-based genome-wide copy-number analysis was conducted using OncoScan FFPE Microarrays (Affymetrix, Santa Clara, California, USA). For the assay, an input amount of 79.2 ng DNA was used. The OncoScan® assay utilizes the molecular inversion probe technology (MIP), which is optimized for highly degraded FFPE samples, for the identification of copy number (CN) alterations, loss of heterozygosity (LOH) and somatic mutations (SMs). MIP probes in the OncoScan® assay capture the alleles of over 220,000 SNPs within ~900 cancer genes. Furthermore, the MIP probes also enable detection of 74 frequently tested somatic mutations in nine genes implicated in cancer (BRAF, KRAS, EGFR, IDH1, IDH2, PTEN, PIK3CA, NRAS and TP53). The molecular inversion probe processing was done according to the OncoScan FFPE Assay Kit Protocol (Affymetrix, Santa Clara, California, USA). At the end of the hybridization period, arrays were stained and washed using the GeneChip® Fluidics Station 450 and loaded into the GeneChip® Scanner 3000 7G (Affymetrix, Santa Clara, California, USA) where array fluorescence intensity was scanned to generate array images (DAT file). Array fluorescence intensity (CEL) files were automatically generated from DAT files by the Affymetrix® GeneChip® Command Console® (AGCC) Software version 4.0. Resulting data files (CEL files) were processed and viewed by using Chromosome Analysis Suite (ChAS) software version 4.2.0.80.
Copy number analysis of Affymetrix 100K and 500K SNP arrays was performed for penile carcinoma cell lines from one patient resistant against 5FU and CDDP as well as both agents.
 
Contributor(s) Winkelmann R, Doering C
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Nov 25, 2022
Last update date Nov 18, 2023
Contact name Ria Winkelmann
E-mail(s) winkelmann@em.uni-frankfurt.de
Organization name Dr. Senckenberg Institute of Pathology Frankfurt am Main
Street address Theodor-Stern-Kai 7
City Frankfurt am Main
ZIP/Postal code 60596
Country Germany
 
Platforms (1)
GPL18602 [OncoScan] Affymetrix OncoScan FFPE Assay
Samples (5)
GSM6756468 Primary tumor sample
GSM6756469 UKF-PEC untreated
GSM6756470 PEC-CDDP
Relations
BioProject PRJNA905440

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE218782_RAW.tar 123.3 Mb (http)(custom) TAR (of CEL, OSCHP)
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap